Moreover, PAX3 expression demonstrates significant positive correlations with multiple immune checkpoints, particularly PDCD1, SIGLEC7, and LILRB2, underscoring its involvement in immune regulation within the glioma microenvironment (Figure 7I). This evidence concerns the gene PAX3 and central nervous system cancer.